Exact Mass: 344.0829

Exact Mass Matches: 344.0829

Found 7 metabolites which its exact mass value is equals to given mass value 344.0829, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

1-Benzenesulfonyl-5-ethyl-5-phenylhydantoin

1-(benzenesulfonyl)-5-ethyl-5-phenylimidazolidine-2,4-dione

C17H16N2O4S (344.0831)


   

2-Chloro-21H,23H-porphyrin

4-chloro-21,22,23,24-tetraazapentacyclo[16.2.1.1^{3,6}.1^{8,11}.1^{13,16}]tetracosa-1,3,5,7,9,11,13(22),14,16,18(21),19-undecaene

C20H13ClN4 (344.0829)


   

MLS 0038949

2,5-dimethoxy-N-quinolin-3-ylbenzenesulfonamide

C17H16N2O4S (344.0831)


   

2-Chloro-21H,23H-porphyrin

2-Chloro-21H,23H-porphyrin

C20H13ClN4 (344.0829)


   

2-mercapto-6,7,8-trimethoxy-3-phenylquinazolin-4(3H)-one

2-mercapto-6,7,8-trimethoxy-3-phenylquinazolin-4(3H)-one

C17H16N2O4S (344.0831)


   

5-Chloroporphyrin

5-Chloroporphyrin

C20H13ClN4 (344.0829)


   

MPT0E028

MPT0E028

C17H16N2O4S (344.0831)


MPT0E028 is an orally active and selective HDAC inhibitor with IC50s of 53.0 nM, 106.2 nM, 29.5 nM for HDAC1, HDAC2 and HDAC6, respectively[1]. MPT0E028 reduces the viability of B-cell lymphomas by inducing apoptosis and possesses potent direct Akt targeting ability and reduces Akt phosphorylation in B-cell lymphoma. MPT0E028 has good anticancer activity[2].